| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/06/2003 | WO2002016582A3 Human sodium-sugar symporter family member and uses thereof |
| 02/06/2003 | WO2002016418A3 An iap binding peptide or polypeptide and methods of using the same |
| 02/06/2003 | WO2002016413A8 Cripto tumour polypeptide |
| 02/06/2003 | WO2002014470A3 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/06/2003 | WO2002012528A3 Enhanced 2-keto-l-gulonic acid production |
| 02/06/2003 | WO2002010217A9 Endothelial cell expression patterns |
| 02/06/2003 | WO2002006499A3 Zmaxig1-specific polynucleotides and methods of use |
| 02/06/2003 | WO2002004596A9 Diagnosing and treating cancer cells using mutant viruses |
| 02/06/2003 | WO2002000883A3 Rescue of canine distemper virus from cdna |
| 02/06/2003 | WO2002000841A3 58199, a membrane-associated protein and uses therefor |
| 02/06/2003 | WO2002000717A9 Novel co-stimulatory molecules |
| 02/06/2003 | WO2001094617A3 Protein fragment complementation assay based on beta-lactamase |
| 02/06/2003 | WO2001094409A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 02/06/2003 | WO2001093897A9 Angiostatin and endostatin binding proteins and methods of use |
| 02/06/2003 | WO2001085930A9 Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| 02/06/2003 | WO2001079285A9 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
| 02/06/2003 | WO2001077330A3 G protein-coupled receptors |
| 02/06/2003 | WO2001075179A3 Preprocalcitonin as tumor rejection antigen precursor and uses thereof |
| 02/06/2003 | WO2001070765A9 Receptor-binding compounds and methods for identifying them |
| 02/06/2003 | WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/06/2003 | WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 02/06/2003 | WO2001005437A3 Methods for treatment of hyperproliferative diseases using human mda-7 |
| 02/06/2003 | WO2001004335A8 Human-bovine chimeric respiratory syncytial virus vaccines |
| 02/06/2003 | US20030028927 Detecting genome vvariation in plants; obtain plant, extract nucleotide sequences, incubate with probe, monitor pattern, compare to control, detect adjsustment in hybridization pattern |
| 02/06/2003 | US20030028926 Recovering human nucleotide sequences from plant genome; obtain human clone from library, incubate with plant cells, transform, recover trangenic plants, propagate, detect snd recover library sequences in offspring genome |
| 02/06/2003 | US20030028921 Polypeptide for use in generating disease resistant plants |
| 02/06/2003 | US20030028920 Antimicrobial polypeptides and their uses |
| 02/06/2003 | US20030028918 Method of imparting drought resistance to plants |
| 02/06/2003 | US20030028914 Analysis of genomic expression of genetically engineered plants; obtain plants, transform with heterologous gene, express genes, monitor exression, screen library for similarly recorded expression patterns |
| 02/06/2003 | US20030028911 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 02/06/2003 | US20030028910 Animal model for use in the diagnosis and treatment dietetics |
| 02/06/2003 | US20030028909 Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders |
| 02/06/2003 | US20030028907 Nucleotide sequences coding polypeptide for use in human therapeutics and diagnostics |
| 02/06/2003 | US20030028905 Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms |
| 02/06/2003 | US20030028904 Genes involved in engulfment of dying cells and cell migration |
| 02/06/2003 | US20030028011 Screening effectiveness of viricides; obtain virally infected cells, expose to viricide, monitor viral gene expression, reduced viral expression indicates viricides |
| 02/06/2003 | US20030028010 Viral nucleotide sequene clone for use as tool in the treatment of viral diseases |
| 02/06/2003 | US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders |
| 02/06/2003 | US20030028007 Vascular endothelial growth factor 2 |
| 02/06/2003 | US20030028006 Cytokine receptor common gamma chain like |
| 02/06/2003 | US20030028005 Mammalian proteins; related reagents and methods |
| 02/06/2003 | US20030028003 Nucleotide sequences codng polypeptide for use in the treatment, diagnosis and prevention inflammation and cancer |
| 02/06/2003 | US20030028002 Cyclin D binding factor, and uses thereof |
| 02/06/2003 | US20030028001 Expression vector for use as tool in the generation of insulin |
| 02/06/2003 | US20030027999 143 human secreted proteins |
| 02/06/2003 | US20030027998 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cardiovascular, nervous system, cancer and infectious disorders |
| 02/06/2003 | US20030027996 Isolation of preferential glycoprotein from sample; obtain sample containing glycoprotein, apply to column, elute and recover preferential glycoprotein from column |
| 02/06/2003 | US20030027995 Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 02/06/2003 | US20030027993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027992 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027991 Method for converting multimers of human serum albumin into monomers thereof |
| 02/06/2003 | US20030027990 Mammalian CX3C chemokine genes |
| 02/06/2003 | US20030027989 Nucleotide seq uences coding polypeptide for use in the diagnosis and treatment of cancer |
| 02/06/2003 | US20030027988 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors |
| 02/06/2003 | US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same |
| 02/06/2003 | US20030027986 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027984 Ligand-binding domain of the ultraspiracle (USP) protein |
| 02/06/2003 | US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders |
| 02/06/2003 | US20030027981 Urokinase-type plasminogen activator receptor |
| 02/06/2003 | US20030027979 Peptide for use in the treatment of infections of the urogenital systems |
| 02/06/2003 | US20030027782 Method for treating allergic lung disease |
| 02/06/2003 | US20030027779 Method for inducing DNA synthesis in neurons |
| 02/06/2003 | US20030027777 Methods for enhancing animal growth and cell proliferation by elimination of the cyclin-dependent kinase inhibitor function of p27Kip1 |
| 02/06/2003 | US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed |
| 02/06/2003 | US20030027774 For diagnosis and therapy of tuberculosis |
| 02/06/2003 | US20030027767 To cause apoptosis in colon cancer and prostate cancer cells |
| 02/06/2003 | US20030027766 Used in cancer therapy and production of potential anti-cancer vaccines |
| 02/06/2003 | US20030027765 Therapeutic peptides having a motif that binds specifically to non-acetylated H3 and H4 histones for cancer therapy |
| 02/06/2003 | US20030027764 Novel therapeutic and prophylactic agents and methods of using same |
| 02/06/2003 | US20030027763 Contacting compound that modulates mast cell degranulation with CD43 polypeptide; determining the functional effect of the compound upon the CD43 polypeptide |
| 02/06/2003 | US20030027761 For enhancing drug delivery; wound healing; adhesion of foreign tissue implanted within a mammal; inducing apoptosis in a JAM-expressing cell |
| 02/06/2003 | US20030027757 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof |
| 02/06/2003 | US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors |
| 02/06/2003 | US20030027753 Bone stimulating factor |
| 02/06/2003 | US20030027752 Leucine-based motif and clostridial neurotoxins |
| 02/06/2003 | US20030027751 For promoting angiogenesis, bone growth, wound healing |
| 02/06/2003 | US20030027750 Useful for diagnosing carcinomas of the uterine cervix, or pre-stages thereof, or those at risk of development of carcinoma |
| 02/06/2003 | US20030027749 For use in therapy, and diagnostic assays |
| 02/06/2003 | US20030027748 For therapy of diabetes |
| 02/06/2003 | US20030027746 Useful in the development of human therapeutics and diagnostic formulations |
| 02/06/2003 | US20030027658 Golf shaft with adjustable stiffness and frequency |
| 02/06/2003 | US20030027358 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 02/06/2003 | US20030027340 Insertion sequence element derived from Ralstonia solanacearum |
| 02/06/2003 | US20030027338 Mutant adenovirus genome for use as vector in genetic engineering |
| 02/06/2003 | US20030027324 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027323 Novel human G-protein coupled receptor, HGPRBMY5, expressed highly in brain and ovarian tissues |
| 02/06/2003 | US20030027322 Genration of herpesvirus amplicon particle for use in the treatment of cancer; obtain nucleotide sequences, incubate with expression vectors, ligate recover viral vector |
| 02/06/2003 | US20030027321 Recombinant RSV virus expression systems and vaccines |
| 02/06/2003 | US20030027320 Promoters for regulated gene expression |
| 02/06/2003 | US20030027319 Artificial antibody polypeptides |
| 02/06/2003 | US20030027318 Cytostatic factor |
| 02/06/2003 | US20030027317 Enzymatic polypeptide for use as tool in the treatment of viral diseases |
| 02/06/2003 | US20030027316 16051a and 16051b, novel human PDZ family members and uses thereof |
| 02/06/2003 | US20030027314 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/06/2003 | US20030027313 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 02/06/2003 | US20030027312 Isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants |
| 02/06/2003 | US20030027309 Genes of purine biosynthesis from ashbya gossypii and the use thereof in microbial riboflavin synthesis |
| 02/06/2003 | US20030027304 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 02/06/2003 | US20030027303 Nucleotide sequences coding enzyme inhibitors for use in biological pest control |